EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure–activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues

Martalu D Pazos, Guillermo García-Díez, David Pubill, Xavier Berzosa, Roger Estrada-Tejedor, Jorge Camarasa, Elena Escubedo, Raúl López-Arnau, Núria Nadal-Gratacós

Archives of Toxicology · 2026-11 · 100 (11) · 5165-5180

DOI: 10.1007/s00204-026-04483-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 27.06.2026. Verfasst von Martalu D Pazos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food…. Hauptthemen laut MEDLINE: Pyrrolidines, Alkaloids, Central Nervous System Stimulants, Pyrrolidinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic cathinones represent the main group of emerging psychostimulants consumed worldwide. Structural modifications of these compounds have led to pyrovalerones, potent dopamine transporter (DAT) inhibitors associated with high abuse liability. Among them, α-pyrrolidinoisohexanophenone (α-PiHP) became the most seized pyrovalerone in the European Union in 2023. Novel analogues have rapidly appeared, yet their neuropharmacological and toxicological properties remain unknown. This study aimed to characterize α-PiHP and five structurally related derivatives (3-Me-α-PiHP, 4-Me-α-PiHP, 3-F-α-PiHP, 4-F-α-PiHP, and MDPiHP). Monoamine transporter activity was evaluated using HEK293 cells expressing human norepinephrine (hNET), hDAT, or serotonin (hSERT) transporters through uptake inhibition and binding assays. Molecular docking was performed to model interactions at hDAT. Psychostimulant, thigmotactic, and rewarding effects were evaluated in male Swiss CD-1 mice using horizontal locomotor activity, open field, and conditioned place preference paradigms. Lethality after drug administration was also assessed. All compounds potently inhibited hDAT and hNET, while displaying limited activity at hSERT. This resulted in high hDAT/hSERT ratios indicative of a stimulant-like profile and elevated abuse liability, confirmed in vivo by pronounced psychostimulant and rewarding effects. All molecules interacted with the orthosteric binding site at hDAT and displayed higher binding affinity than cocaine in in vitro and in silico studies. Meta -substituted analogues showed greater hDAT affinity and behavioural responses than para -isomers. Notably, MDPiHP exhibited the highest potency and affinity, strongest psychostimulant effects and significant lethality. These findings demonstrate that minor structural modifications markedly influence pharmacological activity of pyrovalerone derivatives, highlighting the high abuse potential and health risks associated with emerging α-PiHP analogues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrrolidinesAlkaloidsCentral Nervous System StimulantsPyrrolidinonesAnimalsHumansStructure-Activity RelationshipMaleHEK293 CellsMiceMolecular Docking SimulationDopamine Plasma Membrane Transport ProteinsSynthetic CathinoneComputer SimulationNorepinephrine Plasma Membrane Transport ProteinsSerotonin Plasma Membrane Transport Proteins

Stichwörter der Autor:innen

MDPiHPNew psychoactive substances (NPS)Structure–activity relationship (SAR)Synthetic cathinonesα-PiHP

Substanzen

PyrrolidinesDopamine Plasma Membrane Transport ProteinsAlkaloidsCentral Nervous System StimulantscathinoneSynthetic CathinonePyrrolidinonesNorepinephrine Plasma Membrane Transport Proteinsalpha-pyrrolidinohexanophenoneSerotonin Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.
  • Chemical Reactions for Innovative Solutions (CRISOL), IQS School of Engineering, Universitat Ramon Llull, 08017, Barcelona, Spain.
  • Department of Pharmaceutical Chemistry, IQS School of Engineering, Universitat Ramon Llull, 08017, Barcelona, Spain.
  • Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain. raullopez…
  • Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section, Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain. nurianada…

Förderung

  • Universitat de Barcelona

Zitieren

APA

Pazos, M. D., García-Díez, G., Pubill, D., Berzosa, X., Estrada-Tejedor, R., Camarasa, J., Escubedo, E., López-Arnau, R., & Nadal-Gratacós, N. (2026). Structure–activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues. Archives of Toxicology, 100(11), 5165-5180. https://doi.org/10.1007/s00204-026-04483-z

Vancouver

Pazos MD, García-Díez G, Pubill D, Berzosa X, Estrada-Tejedor R, Camarasa J, et al. Structure–activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues. Archives of Toxicology. 2026;100(11):5165-5180. doi:10.1007/s00204-026-04483-z

BibTeX
@article{Pazos2026,
  author = {Pazos, Martalu D and García-Díez, Guillermo and Pubill, David and Berzosa, Xavier and Estrada-Tejedor, Roger and Camarasa, Jorge and Escubedo, Elena and López-Arnau, Raúl and Nadal-Gratacós, Núria},
  title = {Structure–activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues},
  journal = {Archives of Toxicology},
  year = {2026},
  volume = {100},
  number = {11},
  pages = {5165--5180},
  doi = {10.1007/s00204-026-04483-z}
}
Kostenlos starten →